PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 30 g surgical packs) lidocaine 2.5%, prilocaine 2.5%

Similar documents
PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 5 g and pre-medication packs) lidocaine 2.5%, prilocaine 2.5%

Package leaflet: Information for the user EMLA Cream 5% (for 30 g surgical packs) lidocaine/prilocaine

EMLA. Prilocaine 2.5%, Lignocaine 2.5% CONSUMER MEDICINE INFORMATION

PATIENT INFORMATION LEAFLET. AMETOP GEL 4% w/w Tetracaine

Eumovate Cream clobetasone butyrate

Hair Loss Treatment Regular Strength (Minoxidil)

Betnovate Scalp Application betamethasone valerate. 1 What Betnovate is and what it is used for. 2 What you need to know before you use Betnovate

Dermovate Scalp Application clobetasol propionate

Dermovate Scalp Application clobetasol propionate

Eumovate Ointment clobetasone butyrate

Package leaflet: Information for the user. Trimovate Cream clobetasone 17-butyrate, calcium oxytetracycline and nystatin

Package Leaflet: Information for the User

PATIENT INFORMATION LEAFLET. Hydromol HC Intensive Hydrocortisone and urea

PACKAGE LEAFLET. EN Elastoplast Heat Plaster 11 mg January

Daktacort 2% / 1% w/w cream

Package leaflet: Information for the user. Tactuo 0.1% / 2.5% gel Adapalene/Benzoyl Peroxide

Dermovate Ointment clobetasol propionate

PACKAGE LEAFLET: INFORMATION FOR THE USER. Vaniqa 11.5% cream Eflornithine

DP Fusidic Acid Cream

ClobaDerm 500 micrograms/g Cream & Ointment (clobetasol propionate)

PATIENT INFORMATION LEAFLET. Alphaderm 1% & 10% w/w Cream hydrocortisone and urea

PACKAGE LEAFLET: INFORMATION FOR THE USER. Clindamycin 300 mg Capsules Clindamycin (as hydrochloride)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Isotrex Gel isotretinoin 0.05% w/w

What is in this leaflet 1. What Dalacin Cream is and what it is used for

Rheumon Gel 1 g of gel contains 50 mg of etofenamate. For use in adults.

Package leaflet: Information for the patient. Epiduo 0.3% / 2.5% gel adapalene / benzoyl peroxide

PACKAGE LEAFLET: INFORMATION FOR THE USER. Schollmed Once Weekly Fungal Nail Treatment 5% w/v Medicated Nail Lacquer

Retin-A 0.05% w/w cream

Dermovate Ointment clobetasol propionate

ClobaDerm 0.05% w/w Cream & Ointment (clobetasol propionate)

DUAL ACTION LOGO. Quinoderm 10% / 0.5% w/w Cream Benzoyl Peroxide, hydrous / Potassium Hydroxyquinoline Sulfate

Package leaflet: Information for the user. Versatis 700 mg medicated plaster Lidocaine

1 What Gyno-Daktarin cream is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER. TRAVATAN 40 micrograms/ml eye drops, solution Travoprost

Package Leaflet Information for the User ILUBE 5% w/v eye drops, solution. Acetylcysteine

Package leaflet: Information for the user. ZORAC 0.05% gel ZORAC 0.1% gel. Tazarotene

PATIENT INFORMATION LEAFLET. Timodine Cream

Package leaflet: Information for the user Rogaine 50 mg/g, cutaneous foam. minoxidil

CONSUMER MEDICINE INFORMATION

Occlusal 26%w/w cutaneous solution salicylic acid

ACETOCAUSTIN 0,5 ml, Cutaneous solution

Package leaflet: Information for the patient. Duac Once Daily 10mg/g + 50mg/g Gel clindamycin + anhydrous benzoyl peroxide

Package leaflet: Information for the user. Acnatac 10 mg/g mg/g gel clindamycin and tretinoin

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. TRAVATAN Z Travoprost Ophthalmic Solution

O N C E A DAY. In this leaflet FOR WOMEN

Consumer Medicine Information. Topical Cream Clotrimazole 10 mg/g & Hydrocortisone 10 mg/g

Package leaflet: Information for the user. Vaniqa 11.5% cream Eflornithine

scalp solution 5% w/v minoxidil cutaneous solution to be applied to the scalp

Hydroform Cream 1% Hydrocortisone (microfine) 1% w/w and clioquinol 1% w/ w

PATIENT INFORMATION LEAFLET PUVA TREATMENT. using. Puvasoralen 1.2% Bath Lotion (8-methoxypsoralen)

ISOTREX GEL Isotretinoin 0.05% w/w

A guide for patients who have been prescribed Stelara

Instructions for use. Ixekizumab

Package leaflet: Information for the patient. Onytec 80 mg/g medicated nail lacquer For adults Ciclopirox

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

Package leaflet: Information for the patient SAFLUTAN 15 micrograms/ml Eye drops, solution in single dose-container. Tafluprost

Patient Information Leaflet. Dermal Filler

STELARA INJECTION. What is in this leaflet. Before you use STELARA. What STELARA is used for. Consumer Medicine Information

Dalacin V Cream Clindamycin phosphate

Package leaflet: Information for the user. Regaine for Men Extra Strength Scalp Foam 5% w/w cutaneous foam. Minoxidil

Hydrozole Cream Hydrocortisone (microfine) 1% w/w and clotrimazole 1% w/w

PENTAMYCETIN is an antibiotic that: Stops the growth of bacteria Kills bacteria

v MM 130.2MM FOR WOME N O N C E A D AY

Daivobet 50/500 gel Dye-vo-bet

SIGMACORT cream and ointment

2% w/v Cutaneous Solution Minoxidil PATIENT INFORMATION LEAFLET PANTONE 185 C. 120lpi 0degrees. Black 120lpi 0degrees. Varnish 120lpi 0degrees

Administering ORENCIA (abatacept): Your Step-by-Step Guide

WOMEN'S Regaine EXTRA STRENGTH

Information PROPECIA Finasteride 1mg Tablet

How To Care for Wounds

Dermal Fillers Information Guide

EUMOVATE Clobetasone butyrate 0.05% w/w cream

PACKAGE LEAFLET: INFORMATION FOR THE USER. CURANAIL 5%, medicated nail lacquer Amorolfine

v02 USER INFORMATION LEAFLET 5% w/v Cutaneous Solution Minoxidil for MEN AND WOMEN 139.7mm 69.85mm 69.85mm 130.2mm Inside Cover CELL SIZE 1mm

clindamycin (as phosphate) 1% w/w and tretinoin 0.025% w/w; (klin-da-mye-sin fos-fate) and (tret- i-noin) CONSUMER MEDICINE INFORMATION

Migraine Attack Abortive Treatment Medication Overuse Protocol Treatment Refractory Cluster Headache Treatment

Package leaflet: Information for the patient. Clindamycin ABR 150 mg capsules, hard. Clindamycin ABR 300 mg capsules, hard

Package leaflet: Information for the user. Fredomat 40 microgram/ml oogdruppels, oplossing. Travoprost

POLYTAR Plus Liquid PRODUCT INFORMATION. Polytar Plus Liquid medicated scalp cleanser, contains coal tar solution.

Table of Contents. Adult CPR Infant CPR Caring for a cut Burn Care Use of Epi Pen

TECHNICAL DATA SHEET

Package leaflet: Information for the user. Travoprost Pharmathen 40 microgram/ml, oogdruppels, oplossing Travoprost

Prior to Toenail Surgery Information Sheet

Your Step-by-Step Guide

TECHNICAL DATA SHEET

STELARA INJECTION Ustekinumab (rmc) Consumer Medicine Information

Range. AU-3528 Oct 16. Page 1

ARE YOU? PsA TREAT YOUR SYMPTOMS WITH FOUR DOSES A YEAR. RECOGNIZE THE FOUR SIGNS OF PsA.

EVERYONE WILL NOTICE. No One Will Know.

Psoralen Tablets (Methoxypsoralen)

Skin Allergy Testing Information

MyStelara. For patients who have been prescribed Stelara

Tattoo fading by Laser

Scar management. Patient Information Service. Southend University Hospital NHS Foundation Trust. Rehabilitation department Hand therapy

Why should you self-care? How can my local pharmacist help? How your pharmacist can help

Cosmetic Surgery: Eyelid Surgery (Blepharoplasty)

VASCULAR BIRTHMARKS: SALMON PATCHES, PORT WINE STAINS AND STRAWBERRY MARKS

INFORMATION ABOUT YOUR TREATMENT

PHARMACEUTICALS. Fungal Treatments Viral Treatments Antiseptics Caustics & Cryotherapy Anaesthetics Cold Therapy. algeos.com

Radiotherapy to the skin

Transcription:

PACKAGE LEAFLET: INFORMATION FOR THE USER EMLA Cream 5% (for 30 g surgical packs) lidocaine 2.5%, prilocaine 2.5% Read all of this leaflet carefully before you or your child start using this medicine. This medicine is available without prescription. However, you still need to use EMLA Cream carefully to get the best results from it. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor, pharmacist or nurse. If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, pharmacist or nurse. In this leaflet: 1. What EMLA Cream is and what it is used for 2. Before you use EMLA Cream 3. How to use EMLA Cream 4. Possible side effects 5. How to store EMLA Cream 6. Further information 1. What EMLA Cream is and what it is used for EMLA Cream contains two medicines called lidocaine and prilocaine. These belong to a group of medicines called local anaesthetics. EMLA Cream works by numbing the surface of the skin for a short time. It is put on the skin before certain medical procedures. This helps to stop pain on the skin, however you may still have the feelings of pressure and touch. Adults It can be used to numb the skin before: Having a needle put in (for example, if you are having an injection or a blood test). Minor skin operations. Some types of skin graft. Cleansing and debridement of leg ulcers. It can also be used to numb the genitals before: Having an injection. Medical procedures such as removal of warts. A doctor or nurse should supervise the use of EMLA Cream on the genitals. Children It can be used to numb the skin before: Having a needle put in (for example, if you are having an injection or a blood test). Minor skin operations. 2. Before you use EMLA Cream Do not use EMLA Cream if: You are allergic (hypersensitive) to lidocaine, prilocaine or any of the other ingredients of EMLA Cream (listed in Section 6: Further information). Page 1 of 9

Take special care with EMLA Cream Check with your doctor, pharmacist or nurse before using EMLA Cream if: You or your child are anaemic (a blood problem which means you have too few red blood cells). You or your child have a rare inherited illness that affects the blood called glucose-6- phosphate dehydrogenase deficiency. You or your child have a problem with blood pigment levels called methaemoglobinaemia. You or your child have a skin condition called atopic dermatitis. This is because the cream may need to be put on the skin for a shorter time. Your child is a pre-term newborn infant. Your child is younger than 12 months and is being treated at the same time with other medicines that affect blood pigment levels methaemoglobinaemia. Taking other medicines Please tell your doctor, pharmacist or nurse if you are taking, or have recently taken, any other medicines. This includes medicines that you buy without a prescription and herbal medicines. This is because EMLA Cream can affect the way some medicines work and some medicines can have an effect on EMLA Cream. In particular, tell your doctor, pharmacist or nurse if you or your child have recently used or been given any of the following medicines: Medicines called sulphonamides such as sulfamethoxazole. Other local anaesthetics. Medicines to treat an uneven heart beat, such as mexiletine or amiodarone. Pregnancy and breast-feeding Talk to your doctor, pharmacist or nurse before using EMLA Cream if you are pregnant, may become pregnant or are breast-feeding. The medicines in EMLA Cream (lidocaine and prilocaine) are passed into breast milk. However, the amount is so small that there is generally no risk to the child. Ask your doctor or pharmacist for advice before taking any medicine if you are pregnant or breast-feeding. Important information about some of the ingredients of EMLA Cream EMLA cream contains polyoxyethylene hydrogenated castor oil. This may cause skin reactions. 3. How to use EMLA Cream Always use EMLA Cream exactly as your doctor, pharmacist or nurse has told you. You should check with your doctor, pharmacist or nurse if you are not sure. Do not use EMLA Cream on the following areas: Cuts, grazes or wounds, excluding leg ulcers. Where there is a skin rash or eczema. In or near the eyes. Inside the nose, ear or mouth. In the back passage (anus). On the genitals of children. Page 2 of 9

Using EMLA Cream Where to put the cream, how much to use and how long to leave it on for will depend on what it is needed for. Your doctor, pharmacist or nurse will put the cream on or show you how to do it yourself. If applying the cream yourself, before you do you must get dressings from your doctor, nurse or pharmacist to use with EMLA. When EMLA Cream is used on the genitals, a doctor or nurse should supervise its use. Adults and adolescents aged 12 years and over Use on the skin before small procedures (such as having a needle put in or minor skin operations): The cream is put on to the skin in a thick layer. Your doctor, pharmacist or nurse will tell you where to put it. The usual dose is 2 g applied for 1 to 5 hours under a dressing. Use on the skin before hospital procedures (such as split-skin grafting) that require deeper skin anaesthesia: The usual dose is 1.5 g to 2 g of cream for each area of skin that is 10 cm² (10 square centimetres) in size, applied for 2 to 5 hours under a dressing. The attached User Leaflet for the Healthcare Professional contains further information for your doctor or nurse. Use on larger areas of newly shaven skin before outpatient procedures (such as hair removal techniques): The usual dose is 1.5 g of cream for each area of skin that is 10 cm² (10 square centimetres) in size, applied for 1 to 5 hours under a dressing. EMLA Cream should not be used on an area of newly shaven skin larger than 600 cm² (600 square centimetres, e.g. 30 cm by 20 cm) in size. The maximum dose is 60 g. Use on genital skin before injections of local anaesthetics (adult men only): The usual dose is 1 g of cream for each area of skin that is 10 cm² (10 square centimetres) in size, applied for 15 minutes under a dressing. Use on genital skin before minor skin surgery (such as removal of warts for adults only): The usual dose is 5 g to 10 g of cream applied for 10 minutes with no dressing. The medical procedure should then start immediately. Use on leg ulcers before cleaning or debridement: The usual dose is 1-2g of cream for each area of skin that is 10 cm 2 up to a total of 10 g. The cream is put on under an airtight dressing such as plastic wrap. This is done for 30 to 60 minutes before the ulcer is to be cleansed. Remove the cream with cotton gauze and start cleansing without delay. EMLA Cream can be used before cleansing of leg ulcers for up to 15 times over a period of 1-2 months. Children Use on the skin before small procedures (such as having a needle put in or minor skin operations) Application time: approx. 1 hour. Newborn infants and infants under the age of 3 months: Up to 1 g of cream on a skin area not larger than 10 cm 2 (10 square centimetres) in size. Application time: 1 hour, not more. Only one single dose should be given in any 24 hour period. Page 3 of 9

Infants aged 3-12 months: Up to 2 g of cream on a total skin area not larger than 20 cm 2 (20 square centimetres) in size. Application time: approx 1 hour, maximum 4 hours. Children aged 1-6 years: Up to 10 g of cream on a total skin area not larger than 100 cm 2 (100 square centimetres) in size. Application time: approx 1 hour, maximum 5 hours. Children aged 7-11 years: Up to 20 g of cream on a total skin area not larger than 200 cm 2 (200 square centimetres) in size. Application time: approx 1 hour, maximum 5 hours. A maximum of 2 doses at least 12 hours apart may be given to children over 3 months of age in any 24 hour period. EMLA Cream can be used on children with a skin condition called atopic dermatitis. The application time is 30 minutes. Applying the correct dose Cream applied to a circular area with a diameter of about 18 mm (a 1 pence coin) and depth of about 5 mm is equal to 1 g of EMLA cream. Alternatively, a line of cream of about 3.5 cm squeezed from the 30 g tube is equal to 1 g of cream. When you apply the cream, it is very important to exactly follow the instructions below: 1. Squeeze the cream into a mound where it is needed on your skin (for example where the needle is going to be put in). A line of cream of about 3.5 cm is equal to 1 g of cream. 2. Do not rub the cream in. 3. Peel the centre cut-out from the dressing. 4. Peel the paper layer from the dressing. Page 4 of 9

5. Remove the covers of the dressing. Then place the dressing carefully over the mound of cream. Do not spread the cream under the dressing. 6. Remove the plastic backing. Smooth down the edges of the dressing carefully. Then leave it in place for at least 60 minutes. 7. Your doctor or nurse will take the dressing off and remove the cream just before they do the medical procedure (for example just before the needle is put in). What to do if you get EMLA Cream in your eye Do not get EMLA Cream in your eyes. This is because it may irritate your eyes. If you get EMLA Cream in your eye by mistake, rinse your eye well with lukewarm water or salt (sodium chloride) solution. Be careful to avoid getting anything in your eye until feeling returns. If EMLA Cream is accidentally swallowed, talk to your doctor, pharmacist or nurse straight away. If you use more EMLA Cream than you should If you use more EMLA Cream than your doctor, pharmacist or nurse has told you to, talk to one of them straight away, even if you do not feel any symptoms. Symptoms of using too much EMLA Cream are listed below. These symptoms are unlikely to happen if EMLA Cream is used as recommended. Page 5 of 9

- Feeling light-headed or dizzy. - Tingling of the skin around the mouth and numbness of the tongue. - Abnormal taste. - Blurred vision. - Ringing in the ears. - There is also a risk of acute methaemoglobinaemia (a problem with blood pigment levels). This is more likely when certain medicines have been taken at the same time. If this happens, the skin becomes bluish-grey due to a lack of oxygen. In serious cases of overdose, symptoms may include fits, low blood pressure, slowed breathing, stopped breathing and altered heart beat. These effects may be life-threatening. If you have any further questions on the use of this product, ask your doctor, pharmacist or nurse. 4. Possible side effects Like all medicines, EMLA Cream can cause side effects, although not everybody gets them. Severe allergic reactions (rare, affect less than 1 in 1,000 people) If you have a severe allergic reaction, stop using EMLA Cream and see a doctor straight away. The signs may include sudden onset of: Rash. Feeling short of breath. Low blood pressure, which may make you feel faint or dizzy. Swelling of the face, lips, tongue or other parts of the body. Bluish-grey skin (rare, affects less than 1 in 1,000 people) The skin may become bluish-grey due to a lack of oxygen. If this happens to you, see a doctor straight away. Other possible side effects: Common (affect less than 1 in 10 people) Redness, slight swelling, or pale skin where the cream was used. This usually goes away after a short time. Uncommon (affect less than 1 in 100 people) A mild burning or itching sensation when the cream is put on the skin. (When EMLA Cream is used on the genitals, this is a common side effect, affecting less than 1 in 10 people.) A tingling feeling where the cream was put on the skin. Rare (affect less than 1 in 1,000 people) Mild allergic reactions (which may cause rash or swelling). Small red dots on the skin where the cream was applied. This is more likely in children with skin problems such as atopic dermatitis or mollusca. Eye irritation after getting cream into your eyes by mistake. If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, pharmacist or nurse. Page 6 of 9

5. How to store EMLA Cream Keep out of the reach and sight of children. Do not store above 30 C and do not freeze. Do not use the EMLA Cream after the expiry date which is shown on the tube. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer required. This will help to protect the environment. 6. Further information What EMLA Cream 5% contains The active substances are lidocaine and prilocaine. Each gram of cream contains 25 mg of lidocaine and 25 mg of prilocaine. The other ingredients are polyoxyethylene hydrogenated castor oil, Carbomer 974P, sodium hydroxide and purified water. What EMLA Cream 5% looks like and contents of the pack EMLA Cream 5% is a white soft cream. Your cream will come in a tube containing 30 g of cream without any dressings. A wooden spatula is enclosed for applying your cream. Marketing Authorisation Holder and Manufacturer The Marketing Authorisation for EMLA Cream 5% is held by AstraZeneca UK Limited, 600 Capability Green, Luton, LU1 3LU, UK. EMLA Cream 5% 30 g pack is manufactured by AstraZeneca UK Limited, Silk Road Business Park, Macclesfield, Cheshire, SK10 2NA, UK. To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge: 0800 198 5000 (UK only) Please be ready to give the following information: Product name EMLA Cream 5% Reference number 17901/0120 This is a service provided by the Royal National Institute of Blind People. Leaflet prepared: June 2012 AstraZeneca 2012 EMLA is a trade mark of the AstraZeneca group of companies. PAI 12 0074 Page 7 of 9

User Leaflet for Healthcare Professionals EMLA Cream 5% Application instructions for surgical use only (split skin grafting). Apply approximately 1.5 2 g/10 cm 2 EMLA Cream 5%, at least 2 hours and not more than 5 hours before split skin graft procedure. 1. Shave the skin of the selected donor site area. Clean the area of skin with alcohol. 2. Select the exact area of the donor site by using the graduated ruled edge of this leaflet, e.g. 10 cm x 10 cm or 10 cm x 20 cm and mark this area using an indelible thick marker pen to delineate the margins of the site. 3. Squeeze out between ½ 1 (30 g) tube of EMLA Cream 5% per 100 cm 2 on the area of the donor site to be anaesthetised. 4. Spread the EMLA Cream 5% using the enclosed spatula to form an even, thick layer. It is important to cover completely the entire donor area including over the marked margins of the site. Page 8 of 9

5. Take a strip of transparent occlusive plastic film wrapping cut to the appropriate size (slightly larger than the area of the donor site). Carefully apply the wrapping to cover completely the layer of EMLA Cream 5%. 6. Smooth down and tape the edges of the occlusive film wrapping to the skin using a surgical synthetic adhesive tape. 7. Wrap the entire site using an elastic crepe bandage to protect the site and avoid leakage of the EMLA Cream 5% but avoid undue compression and do not wrap too tight. Leave the EMLA Cream 5% and occlusive wrapping in place for at least 2 hours. As a reminder, the time can be written on the wrapping or bandage. 8. After 1 hour and hourly thereafter remove only the crepe bandage (not the adhesive tape or film wrapping) and massage the EMLA Cream 5% through the film wrapping to ensure a thick, even layer of EMLA is maintained over the entire donor site. Replace the bandage. 9. After a minimum of 2 hours just prior to surgery remove the bandage and occlusive wrapping. Wipe off the EMLA Cream 5%. Analgesic efficacy may decline if application time is >5 hours. The anaesthetised donor site may appear either pale or red. These reactions are normal and are associated with the skin anaesthesia. Disinfect and prepare the anaesthetised donor site prior to cutting the split skin graft. Page 9 of 9